British Journal of Medical & Surgical Urology
Volume 1, Issue 1 , Pages 25-30, July 2008

Age-specific PSA reference values based on a screening population of British men

  • M.H. Winkler

      Affiliations

    • Department of Urology, Imperial College Healthcare NHS Trust, London, UK
    • Corresponding Author InformationCorresponding author at: Department of Urology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, UK.
  • ,
  • E.K. Mayer

      Affiliations

    • Department of Urology, Imperial College Healthcare NHS Trust, London, UK
  • ,
  • A. Carter

      Affiliations

    • Department of Urology, Royal Gwent Hospital, Newport, Gwent, UK
  • ,
  • E. Kulinskaya

      Affiliations

    • Statistical Advisory Service, Imperial College London, UK
  • ,
  • J.S.A. Green

      Affiliations

    • Department of Urology, Whipps Cross Hospital, London, UK

Summary 

Objective

Age-specific PSA reference values are recommended by the Department of Health and NICE as a referral trigger for men with abnormal PSA values. They are arbitrary values in the UK and are based on the international literature.

Patients and methods

Data of 1970 men with benign histology from the Gwent screening study were used out of a cohort of 2063 men. The adaptive trimmed maximum likelihood method as the best way of removing outliers which do not come from a log-normal distribution was used after data transformation. The 95% percentile was used as cut-off value.

Results

The true statistical 95% percentile for PSA in a screening population for the age groups 50–59.9 years, 60–69.9 years and 70–79.9 years are 3.2ng/ml, 5.6ng/ml and 8.1ng/ml, respectively.

Conclusions

These values differ from the recommended referral cut-off values by the Department of Health. The adoption of higher values for the older age groups may be a sensible policy to avoid unnecessary investigation in elder men with high PSA values due to benign disease.

Abbreviations: DRE, digital rectal examination, GP, general practitioner, NICE, National Institute for Clinical Excellence, PSA, prostate specific antigen, TRUS, transrectal ultrasound

Keywords: Prostate cancer, PSA, Age-specific PSA, Prostate neoplasm, PSA screening

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1875-9742(08)00007-4

doi:10.1016/j.bjmsu.2008.05.006

British Journal of Medical & Surgical Urology
Volume 1, Issue 1 , Pages 25-30, July 2008